D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint
Abstract Background Targeting glucose uptake by glucose transporter (GLUT) inhibitors is a therapeutic opportunity, but efforts on GLUT inhibitors have not been successful in the clinic and the underlying mechanism remains unclear.We aim to identify the key metabolic changes responsible for cancer cell survival from glucose limitation and elucidate